202 related articles for article (PubMed ID: 21609388)
1. Cellular evidence of reverse cardiac remodeling induced by cardiac resynchronization therapy.
Orrego CM; Nasir N; Oliveira GH; Flores-Arredondo JH; Cordero-Reyes AM; Loebe M; Youker KA; Torre-Amione G
Congest Heart Fail; 2011; 17(3):140-6. PubMed ID: 21609388
[TBL] [Abstract][Full Text] [Related]
2. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
[TBL] [Abstract][Full Text] [Related]
3. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
Klotz S; Naka Y; Oz MC; Burkhoff D
J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
[TBL] [Abstract][Full Text] [Related]
4. Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium.
D'Ascia C; Cittadini A; Monti MG; Riccio G; Saccà L
Eur Heart J; 2006 Jan; 27(2):201-6. PubMed ID: 16291773
[TBL] [Abstract][Full Text] [Related]
5. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
6. Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy.
Iyengar S; Haas G; Lamba S; Orsinelli DA; Babu GJ; Ferketich AK; Yamokoski L; Periasamy M; Abraham WT
J Card Fail; 2007 May; 13(4):304-11. PubMed ID: 17517351
[TBL] [Abstract][Full Text] [Related]
7. Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading.
Wohlschlaeger J; von Winterfeld M; Milting H; El Banayosy A; Schmitz KJ; Takeda A; Takeda N; Azhari P; Schmid C; August C; Schmid KW; Baba HA
J Heart Lung Transplant; 2008 Apr; 27(4):442-9. PubMed ID: 18374882
[TBL] [Abstract][Full Text] [Related]
8. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
[TBL] [Abstract][Full Text] [Related]
9. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
[TBL] [Abstract][Full Text] [Related]
10. Plasma osteopontin reveals left ventricular reverse remodelling following cardiac resynchronization therapy in heart failure.
Francia P; Balla C; Ricotta A; Uccellini A; Frattari A; Modestino A; Borro M; Simmaco M; Salvati A; De Biase L; Volpe M
Int J Cardiol; 2011 Dec; 153(3):306-10. PubMed ID: 20863582
[TBL] [Abstract][Full Text] [Related]
11. Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up.
Verhaert D; Grimm RA; Puntawangkoon C; Wolski K; De S; Wilkoff BL; Starling RC; Tang WH; Thomas JD; Popović ZB
J Am Coll Cardiol; 2010 Apr; 55(17):1788-95. PubMed ID: 20413027
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cardiac Resynchronization Therapy on Myocardial Fibrosis and Relevant Cytokines in a Canine Model With Experimental Heart Failure.
Wang J; Gong X; Chen H; Qin S; Zhou N; Su Y; Ge J
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):438-445. PubMed ID: 28127817
[TBL] [Abstract][Full Text] [Related]
13. Myocardial collagen metabolism in failing hearts before and during cardiac resynchronization therapy.
Umar S; Bax JJ; Klok M; van Bommel RJ; Hessel MH; den Adel B; Bleeker GB; Henneman MM; Atsma DE; van der Wall EE; Schalij MJ; van der Laarse A
Eur J Heart Fail; 2008 Sep; 10(9):878-83. PubMed ID: 18768351
[TBL] [Abstract][Full Text] [Related]
14. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
15. Relationship between acute improvement in left ventricular function to 6-month outcomes after cardiac resynchronization therapy in patients with chronic heart failure.
Pires LA; Ghio S; Chung ES; Tavazzi L; Abraham WT; Gerritse B
Congest Heart Fail; 2011; 17(2):65-70. PubMed ID: 21449994
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
17. Recoordination rather than resynchronization predicts reverse remodeling after cardiac resynchronization therapy.
Wang CL; Wu CT; Yeh YH; Wu LS; Chang CJ; Ho WJ; Hsu LA; Luqman N; Kuo CT
J Am Soc Echocardiogr; 2010 Jun; 23(6):611-20. PubMed ID: 20418055
[TBL] [Abstract][Full Text] [Related]
18. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
